Suchergebnisse - "Personeni, Nicola"

PubPharm (10)

1

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

enthalten in: Cancers | 2022

von Wu, Y. | Fulgenzi, C. | D'Alessio, A. | +32

2

Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment

enthalten in: Journal of personalized medicine | 2022

von Personeni, N. | Pressiani, T. | Zanuso, V. | +10

3

The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

enthalten in: Cancers | 2021

von Muhammed, A. | Fulgenzi, C. | Dharmapuri, S. | +36

4

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors

enthalten in: Cancers | 2021

von Personeni, N. | Pressiani, T. | D'Alessio, A. | +13

5

Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma

enthalten in: Therapeutic advances in medical oncology | 2021

von Jun, T. | Ozbek, U. | Dharmapuri, S. | +22

6

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction : Adjunctive Role of the ALBI Grade

enthalten in: Cancers | 2020

von Pinato, D. | Kaneko, T. | Saeed, A. | +23

7

Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib

enthalten in: Future oncology (London, England) | 2019

von Personeni, N. | Pressiani, T. | Rimassa, L.

8

Lenvatinib for the treatment of unresectable hepatocellular carcinoma : evidence to date

enthalten in: Journal of hepatocellular carcinoma | 2019

von Personeni, N. | Pressiani, T. | Rimassa, L.

9

Regorafenib in hepatocellular carcinoma : latest evidence and clinical implications

enthalten in: Drugs in context | 2018

von Personeni, N. | Pressiani, T. | Santoro, A. | +1

10

Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

enthalten in: Oncotarget | 2017

von Personeni, N. | Giordano, L. | Abbadessa, G. | +15

1
[1]